
Unitree's $610M Shanghai IPO Registration Approved, Igniting A-Share Robot Stock Frenzy
China's securities regulator has approved Unitree Robotics' STAR Market IPO registration, sending more than 30 robot-concept stocks to their daily limit as the humanoid maker targets a valuation above 100 billion yuan.
Unitree Robotics has cleared the final regulatory hurdle for its Shanghai STAR Market listing, with China's securities regulator approving the humanoid robot maker's IPO registration and setting off a buying frenzy that sent more than 30 robot-concept stocks to their daily limit in a single session.
A landmark listing for embodied AI
The Hangzhou-based company plans to raise approximately 4.2 billion yuan — around $610 million — in what has become the most closely watched listing in China's robotics sector. Market expectations have anchored Unitree's valuation above 100 billion yuan, roughly $14.7 billion, making it the first pure-play humanoid company to command that scale on the mainland.
The approval caps a rapid ascent for Unitree, which built its reputation on quadruped robots before its humanoid H1 and G1 lines turned it into the face of China's embodied-AI push. The company was earlier selected by Nvidia as a launch partner for its GR00T humanoid platform.
Frenzy meets fundamentals
The registration triggered an immediate rally across the A-share robotics complex, with component suppliers, actuator makers and sensor firms surging in sympathy. Analysts described the reaction as a shift in the sector's narrative from research promise to earnings validation — though Unitree's own prospectus offers a note of caution.
First-quarter revenue growth decelerated sharply to 68 percent, and net profit halved year-over-year. The filing explicitly warns of intensifying price competition from Tesla and from Chinese automakers that have piled into humanoid development with deep balance sheets.
What comes next
Proceeds will fund capacity expansion, next-generation actuators and the AI models that drive Unitree's robots. The listing lands in the same window as Agility Robotics' $2.5 billion SPAC deal in the United States and Tesla's conversion of a Fremont line to Optimus production — a remarkable convergence that has pushed humanoid robotics from lab demos to public markets in a single year.
Newsletter
Get Lanceum in your inbox
Weekly insights on AI and technology in Asia.


